BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 26566030)

  • 21. [Interaction of DAXX and human papillomavirus type 16 E2 protein].
    Tang SY; Li L; Liu Y; Liu AY; Yu MJ; Zhang Y; Liu LZ; Wan YP
    Mol Biol (Mosk); 2014; 48(4):682-6. PubMed ID: 25842852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of Pax3 transcriptional activity by SUMO-1-modified PML.
    Lehembre F; Müller S; Pandolfi PP; Dejean A
    Oncogene; 2001 Jan; 20(1):1-9. PubMed ID: 11244500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis.
    Zhong S; Salomoni P; Ronchetti S; Guo A; Ruggero D; Pandolfi PP
    J Exp Med; 2000 Feb; 191(4):631-40. PubMed ID: 10684855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of promyelocytic leukemia protein in host antiviral defense.
    Geoffroy MC; Chelbi-Alix MK
    J Interferon Cytokine Res; 2011 Jan; 31(1):145-58. PubMed ID: 21198351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon-induced antiviral Mx1 GTPase is associated with components of the SUMO-1 system and promyelocytic leukemia protein nuclear bodies.
    Engelhardt OG; Ullrich E; Kochs G; Haller O
    Exp Cell Res; 2001 Dec; 271(2):286-95. PubMed ID: 11716541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation.
    Li Q; He Y; Wei L; Wu X; Wu D; Lin S; Wang Z; Ye Z; Lin SC
    Oncogene; 2011 Mar; 30(10):1194-204. PubMed ID: 21057547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamics of component exchange at PML nuclear bodies.
    Weidtkamp-Peters S; Lenser T; Negorev D; Gerstner N; Hofmann TG; Schwanitz G; Hoischen C; Maul G; Dittrich P; Hemmerich P
    J Cell Sci; 2008 Aug; 121(Pt 16):2731-43. PubMed ID: 18664490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Death domain-associated protein DAXX promotes ovarian cancer development and chemoresistance.
    Pan WW; Zhou JJ; Liu XM; Xu Y; Guo LJ; Yu C; Shi QH; Fan HY
    J Biol Chem; 2013 May; 288(19):13620-30. PubMed ID: 23539629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Daxx-beta and Daxx-gamma, two novel splice variants of the transcriptional co-repressor Daxx.
    Wethkamp N; Hanenberg H; Funke S; Suschek CV; Wetzel W; Heikaus S; Grinstein E; Ramp U; Engers R; Gabbert HE; Mahotka C
    J Biol Chem; 2011 Jun; 286(22):19576-88. PubMed ID: 21482821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DAXX silencing suppresses mouse ovarian surface epithelial cell growth by inducing senescence and DNA damage.
    Pan WW; Yi FP; Cao LX; Liu XM; Shen ZF; Bu YQ; Xu Y; Fan HY; Song FZ
    Gene; 2013 Sep; 526(2):287-94. PubMed ID: 23542781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural and functional characterization of the phosphorylation-dependent interaction between PML and SUMO1.
    Cappadocia L; Mascle XH; Bourdeau V; Tremblay-Belzile S; Chaker-Margot M; Lussier-Price M; Wada J; Sakaguchi K; Aubry M; Ferbeyre G; Omichinski JG
    Structure; 2015 Jan; 23(1):126-138. PubMed ID: 25497731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EBV tegument protein BNRF1 disrupts DAXX-ATRX to activate viral early gene transcription.
    Tsai K; Thikmyanova N; Wojcechowskyj JA; Delecluse HJ; Lieberman PM
    PLoS Pathog; 2011 Nov; 7(11):e1002376. PubMed ID: 22102817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel transcription regulatory complex containing death domain-associated protein and the ATR-X syndrome protein.
    Tang J; Wu S; Liu H; Stratt R; Barak OG; Shiekhattar R; Picketts DJ; Yang X
    J Biol Chem; 2004 May; 279(19):20369-77. PubMed ID: 14990586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Promyelocytic Leukemia Protein Potently Restricts Human Cytomegalovirus Infection in Endothelial Cells.
    Seitz S; Heusel AT; Stamminger T; Scherer M
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Release of RASSF1C from the nucleus by Daxx degradation links DNA damage and SAPK/JNK activation.
    Kitagawa D; Kajiho H; Negishi T; Ura S; Watanabe T; Wada T; Ichijo H; Katada T; Nishina H
    EMBO J; 2006 Jul; 25(14):3286-97. PubMed ID: 16810318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells.
    Herzer K; Weyer S; Krammer PH; Galle PR; Hofmann TG
    Cancer Res; 2005 Dec; 65(23):10830-7. PubMed ID: 16322229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role and fate of PML nuclear bodies in response to interferon and viral infections.
    Regad T; Chelbi-Alix MK
    Oncogene; 2001 Oct; 20(49):7274-86. PubMed ID: 11704856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of the Major ND10 Proteins PML, hDaxx and Sp100 to the Regulation of Human Cytomegalovirus Latency and Lytic Replication in the Monocytic Cell Line THP-1.
    Wagenknecht N; Reuter N; Scherer M; Reichel A; Müller R; Stamminger T
    Viruses; 2015 Jun; 7(6):2884-907. PubMed ID: 26057166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual roles for lysine 490 of promyelocytic leukemia protein in the transactivation of glucocorticoid receptor-interacting protein 1.
    Liu ST; Lu GY; Hsu YJ; Chang LC; Ho CL; Huang SM
    Biochim Biophys Acta; 2013 Aug; 1833(8):1799-810. PubMed ID: 23542129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterochromatin and ND10 are cell-cycle regulated and phosphorylation-dependent alternate nuclear sites of the transcription repressor Daxx and SWI/SNF protein ATRX.
    Ishov AM; Vladimirova OV; Maul GG
    J Cell Sci; 2004 Aug; 117(Pt 17):3807-20. PubMed ID: 15252119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.